Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity — Steven Deitelzweig (2021) | RDL Network
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Article 2021 en
Authors
SD
Steven Deitelzweig
AK
Allison Keshishian
AK
Amiee Kang
Abstract
1 min read
Among patients with NVAF and six or more comorbid conditions, NOACs were associated with varying risk of stroke/SE and MB compared to warfarin and to each other. Rather than a "one drug fits all" approach, our results may be useful for appropriate OAC treatment for multimorbid patients.
Professor Gregory Lip, Allison Keshishian, A Kang, X Luo, Nipun Atreja, Y Zhang, Patricia Schuler, Jenny Jiang, K Lovett, Hüseyin Yüce, Steven Deitelzweig
Professor Gregory Lip, Allison Keshishian, A Kang, X Luo, Nipun Atreja, Y Zhang, Patricia Schuler, Jenny Jiang, K Lovett, Hüseyin Yüce, Steven Deitelzweig
Steven Deitelzweig, Allison Keshishian, Xiaoyan Li, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Xianying Pan, Anagha Nadkarni, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Professor Gregory Lip
Professor Gregory Lip, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, X. Li, N. Balachander, Lisa Rosenblatt, Jack Mardekian, Xiangbin Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Steve Deitelzweig
Professor Gregory Lip, Allison Keshishian, Yan Zhang, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Hüseyin Yüce, Steven Deitelzweig
Discussion(0)
No comments yet. Be the first to comment.